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Abstract: Background: South Africa recently adopted HIV self-test technology (HIVST) to improve
HIV testing and encourage earlier treatment initiation in working populations with a low uptake of
conventional testing approaches. This study investigates the impact of HIVST on testing outcomes,
focusing on both frequent and infrequent working-class testers. The paper also examines the spillover
effect of HIVST on antiretroviral (ART) treatment initiation. To identify these effects, the author
focused on South Africa and exploited the HIVST distribution data of 6259 beneficiaries of HIVST.
Methods: The author used a two-stage least-squared model to quantify the impact of the HIVST on
these vulnerable working populations. Results: The results show that HIVST fosters a 27.6% higher
testing uptake in infrequently testing workers compared to frequently testing workers, and that
the uptake of HIVST is 11.5% higher in rural regions than in urban settings, as well as 14.5% more
prominent in infrequent male testers than infrequent female testers. Notably, the positive effects of
HIVST are also confirmed by the presence of positive spillover effects in workers screening positive
for HIV. The paper documents a 7.6% increase in ART initiation in infrequent testers. Conclusions:
There is a case for adopting this technology to improve the uptake of HIV testing and ART initiation
as the country seeks to attain the UNAIDS 95–95–95 targets by 2030.
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1. Introduction
In 2014, the United Nations (UN) Programme on HIV/AIDS (UNAIDS) announced
UNAIDS 95–95–95 targets to end the AIDS epidemic by 2030 [1]. Based on this publication,
it was clear that low HIV testing may undermine the global efforts to tackle HIV by 2030,
especially in crucial vulnerable African populations [2,3].
Hence, there was a need to find innovative strategies to improve HIV testing, especially
in populations with a low uptake of conventional testing approaches [4]. In 2016, the World
Health Organisation (WHO) responded to the concerns of the low testing rate by publishing
the first global guidelines on HIV self-testing, in which HIV self-testing was recommended
as an additional method besides the current conventional testing approaches [5]. It was
suggested that HIV self-testing technology has superior specificity [6,7], and that it may
improve HIV testing in vulnerable populations.
Currently, the South African health system is battling low rates of HIV testing, especially in the working population. As a result, in 2017, South Africa adopted the HIV
Self-Test Technology (HIVST) to improve HIV testing uptake in the working population
group. The working class in South Africa has a low appetite for HIV testing [8]. Hence, the
workplace distribution of HIVST was implemented—aimed at improving testing uptake—and
ART initiation across ten different industries in urban (Gauteng) and predominantly rural
provinces (Mpumalanga and North West), with a particular focus on those employees who
had never tested before or were infrequent testers, meaning their latest test was done more
than 12 months ago.
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This technology was implemented based on evidence that the lack of confidentiality is
one of the major contributing factors that limited testing uptake in workers [8,9]. Thus, it
was recommended for South Africa to change the HIV testing algorithm [10] by targeting
the working class and offering them HIV self-testing kits. Some suggested that HIVST
may increase the demand for testing in the working populations [11]. In turn, this would
enhance the UN 95-95-95 targets.
However, other scholars are sceptical of this view and argue that HIVST does not
improve ART uptake [12]. In Lesotho, for example, HIVST distribution failed to improve
testing in the vulnerable adolescent population [13]. Therefore, the idea that HIVST is a
robust technology to advance the UN 95-95-95 targets may not be valid.
Despite the recent adoption of HIVST in South Africa and the growing debate around
this technology, there has not yet been a study done to analyse the impact of HIVST on
testing outcomes in the South African workplace environment. No study has explored both
the regional and gender differences of HIVST effects.
Furthermore, no study has analysed the spillover effects of HIVST on ART initiations,
focusing on workplace distribution. All these exercises are essential in informing policymakers about the robustness of HIVST in driving improvements of HIV epidemiology in
the workplace environment. The current study seeks to address these gaps, and it explores
the impact of HIVST on the testing uptake of infrequent testers and the spillover effects on
ART initiation.
The study focused on two population groups—frequent and infrequent testers within
the working-class population—and sought to answer the following questions: (1) What
impact does HIVST exert on the testing uptake of infrequent testers? (2) Are there gender
and regional differences in the impact of HIVST? (3) Is HIVST likely to influence ART
initiation positively? The author believes that providing answers to these interrelated
questions unlocks the understanding of the potential legacy of HIVST in advancing health
goals in the workplace environment.
2. Material and Methods
2.1. Workplace HIVST Distribution and Data Collection
The workplace distribution of HIVST was predominantly conducted in male-dominated
sectors such as manufacturing, mining, construction, security, petroleum, and agriculture by
the HIVST implementation partners in Mpumalanga, Gauteng, and North West provinces
from the year 2017–2020. Two types of workplaces were included: (a) larger companies that
did not have formalized HIV testing programs or had a significantly low HIV testing uptake.
These companies were contacted before the distribution event for sensitization; (b) smaller
workplaces, such as petrol stations or construction sites, without prior arrangement with
management [14].
Before distribution took place, the distribution agents demonstrated how the HIVST
kit works to a group of employees using video or physical demonstration. After the
demonstration, HIVST kits were distributed to consenting clients. Kits were distributed to
employees in a brown paper bag with the intervention logo. The bag contained:

•
•
•
•

an oral-fluid-based self-testing kit,
the instruction leaflet,
a referral card with instructions for further action in the event of a positive screening result,
a contact number for a representative of the organization distributing the kits.

Kits were distributed to all employees interested in self-screening; about 15% of
employees were also offered a kit to take home and offer to their partners. Those testing
positive using HIVST were advised to contact the nearby health facility for confirmatory
testing, which included the usual counselling session. A list of clinics in the vicinity of the
company was provided separately.
Clients who chose to take up HIVST were given an option of self-testing in one of
the small tents on-site or taking the kit home for their private use. Confirmatory testing
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conducted by a professional provider was offered on-site for workers screening positive
on-site. Data were also collected on-site, capturing the previous HIV testing history of
the worker, age, distribution date, employment sector, gender, region, and the number of
kits collected. The primary outcome of this data collection strategy was to discover the
population groups with the highest testing appetite for using the HIVST. The secondary
outcome was to explore the spillover effect of HIVST distribution on antiretroviral (ART)
treatment initiation.
Primary recipients of HIVST consenting to telephonic follow-up calls provided their
cell phone numbers during distribution. These workers were followed up telephonically with up to three calls at approximately 2-week, 4-week, and 6-week time intervals
post-distribution. During the call, a trained linkage officer administered a standardized
questionnaire in order to record kit usage, the HIVST result, and whether recipients had
attended confirmatory testing and initiated ART, in the case of a positive result.
This paper analyses the outcomes of 6259 workers who confirmed to have used the
HIVST kits (See Figure 1). Furthermore, the paper also explores the spillover effects of
HIVST onto ART initiation by using the probability that infrequently testing workers
screening positive with HIVST will opt for ART initiation as an outcome. The author
excluded clients who had not confirmed HIVST usage. Figure 1 shows the schematic flow
of the workplace distribution model.
2.2. Statistical Analysis
In order to study the impact of the HIVST technology on testing outcomes, the author
defined treatment and control groups based on previous testing history with conventional
testing methods using rapid tests. Workers who tested for HIV 3 months before opting
for HIVST were defined as frequent testers. Workers who have never tested for HIV in
their lifetime, or whose last test was 12 months before opting for HIVST, were defined as
infrequent testers. The author considered infrequent testers as the treatment group and
frequent testers as the control group because this group has frequently been testing, even
without HIVST availability. Thus, the author uses the variations in the testing history to
identify the impacts of HIVST on the testing uptake of infrequently testing workers and
spillover effects on ART initiation.
The author has reasons to believe these probability estimations may overestimate or
underestimate the effects of the HIVST on testing and ART outcomes. Hence, the author
opted for a two-stage least-squared (2SLS) model to control for possible biases, instead of
the usual ordinary least-squared (OLS) model. Furthermore, several health-policy studies
in South Africa have utilized the 2SLS model as a reliable econometric technique to advance
health policy analyses [15–18].
The two-stage least-squared (2SLS) model that was estimated is as follows:
Yia = α1 + β 1 “H IVSTi a ” + δAgeFE + λindustryFE + θRegionFE + ρMonthFE + ξ Intensityi + σFemalei
H IVSTia = α2 + β 2 Treatia + δAgeFE + λindustryFE + θRegionFE + ρMonthFE + ξ Intensityi + σFemalei
In the first equation, “Y” is the HIV outcome for individual “i” in each group “a”
(defined as frequent or infrequent testers), and “HIVST” is the predicted receipt of the
HIVST technology.
The regression includes age fixed effects (FE) (which capture age differences in our
sample), industry fixed effects (including all industries that had workplace HIVST distributions under WRHI), regional fixed effects (including all municipality regions where HIVST
kits were distributed), calendar-month fixed effects (which capture the different months
of HIV self-testing distribution), a dummy for intensity (which captures the distribution
intensity in individuals who received more than one kit), and a dummy for female (for the
regressions in which the author estimates effects for both males and females).
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testing than older cohorts [19]. Hence, the author opted to control these biases using the age
control dummy variable. The industry dummy variable control is used for HIV difference
across South African industries. It is documented that specific workplaces, for example
mining workplaces, have comprehensive HIV testing services, while other industries lack
them [8]. Hence, the author opted to control these industry biases using the industry
dummy variable. The region dummy variable controls the regional biases of the program.
For example, there is a higher demand for HIV services in rural regions than in urban
settings, due to a lack of resources [20]. Therefore, controlling for these regional biases is
ideal. The month dummy variable controls the seasonal differences in HIV testing. The
demand for HIV testing is lower in the winter compared to summer in South Africa. The
author opted to control for these seasonality biases. The intensity dummy variable controls
the distribution biases in the subjects that receive more than one kit. Testing uptake may
be high, driven by the excitement of the newly adopted testing technology—the intensity
dummy variable controls for these biases. The gender dummy variable controls the gender
biases of HIV testing. For example, men are known to have a lower appetite for HIV testing
than women [21]. Hence, the gender control dummy variable mitigates these gender biases.
In the second equation (which corresponds to the first stage regression), participation
in the HIVST distribution program is estimated as a function of the treatment dummy
variable, which identifies infrequently testing individuals who confirmed that they had
used an HIVST kit.
In all model estimations, one needs two assumptions to be fulfilled: first, the instrument has to be relevant in explaining the probability of HIV outcomes, which will be
corroborated by the F-test of the first stage equation; and second, the exclusion restriction
needs to hold; that is, the instrument should not influence the primary outcome directly
through any channel other than the treatment effect of HIVST distribution.
In the current case, this assumption means that differences in testing and ART outcomes between the treated and control groups can only be due to HIVST technology. Since
the paper included month and intensity fixed effects, the author is capturing any improvement in testing and ART uptake attributed to the HIVST technology, without the program’s
seasonality and distribution intensity biases.
For example, there is no reason to believe that the treatment group should have a
higher testing uptake and ART initiation than the control group when observed in the
same regions and industries. Furthermore, no other event in the South African health
system explains any difference in testing outcomes that would affect only the treatment
group, but not the control group. For this reason, the author is confident that the exclusion
restriction is satisfied in this case, meaning these changes can only be explained by HIVST
technology distribution.
3. Results
3.1. Descriptive Analysis
Table 1 presents the average percentage breakdown of testing and ART uptake in the
treatment and control groups. This analysis captures 6259 individuals who confirmed the
HIVST kit usage. No spoiled kits were reported from the sample of 6259 individuals.
Table 1. Summary statistics—workplace HIVST distribution model.
Variable

Treated Cohorts

Control Cohorts

Reported testing uptake
Reported testing uptake in males
Reported testing uptake in females
Reported testing uptake in urban settings
Reported testing uptake in rural settings
Reported ART uptake
Observations

55%
56%
54%
52%
56%
61%
3255

45%
44%
46%
48%
44%
39%
3004
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Table 1 shows that 55% of infrequent testers (treated cohorts) opted to test for HIV
using the self-test technology compared to the 45% who belong to the frequent testing
population (control cohorts). Moreover, 56% of infrequent male testers opted to test for
HIV using the self-test technology compared to the 44% of men who belong to the frequent
testing population. About 54% of infrequent female testers opted to test for HIV using the
self-test technology compared to the 46% of females who belong to the frequent testing
population. Likewise, 52% of infrequent urban testers opted to test for HIV using the
self-test technology compared to the 48% of urban clients who belong to the frequent
testing group. Additionally, 56% of infrequent rural testers opted to test for HIV using
this technology compared to 44% of rural clients who belong to the frequent testing cohort.
Lastly, 61% of infrequent testers opted to initiate ART after testing using the self-test
technology compared to the 39% who belong to the frequent testing population.
3.2. Results of Two-Stage Least-Squared Model
When analysing the results of the 2SLS estimations, in Table 2, the F-statistic of the first
stage regression is very large, pointing towards the strong validity of the cohort instrument.
One can also observe that the cohort variable is a significant proxy for HIVST technology
and a determinant in improving testing uptake. More specifically, the author observed
that the probability of HIVST uptake increases by 25.5 percentage points in the infrequent
testing sub-population. As the mean for test uptake is 92.3 in our sample of HIVST users,
the HIVST increases the probability of infrequent testers opting for testing by 27.6% more
than for frequent testers.
Table 2. The 2SLS estimation of the impact of HIVST on the testing uptake of workers.
2SLS Estimation

Workplace

1st Stage
Treatment (infrequent testing cohort)
Standard errors
p-value

HIVST Technology
0.097
(0.003)
0.003
Confirmed Testing
0.255
(0.003)
0.001
YES
YES
YES
YES
YES
YES
0.923
6259
151.721
0.087

HIVST Technology
Standard errors
p-value
Age fix effect
Industry fix effect
Region fix effect
Month fix effect
Intensity fix effect
Gender fix effect
Mean for HIV testing uptake
Observations
F-stat 1st SLS
R-squared 2nd SLS

Note: The results are from a 2SLS model. In the first stage equation, the dependent variable is the probability of
receiving the HIVST kit, while the instrument is a dummy variable equal to 1, for the infrequent testers, and 0, for
frequent testers. The dependent variable is the “confirmed HIV testing uptake” dummy variable in the second
stage regression. Both regressions include age, industry, region, month, distribution intensity, and gender fixed
effects. Source: Wits RHI workplace data provided by HSTAR group from 3 October 2017 to 31 January 2020.

The paper next examines whether HIVST also positively impacted HIV testing in rural
and urban settings. Table 3 reports the results for the probability of HIV testing in both
settings. The author noted that HIVST distribution increased testing uptake more in rural
than in urban settings. More specifically, HIVST increases testing uptake by 31.5 percentage
points, which implies an improvement of 33.3% in testing uptake for infrequent testing
clients. HIVST increases testing uptake by 19.6 percentage points in the urban settings,
which implies an improvement of 21.8% in testing uptake for infrequent testing clients.
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Table 3. The 2SLS estimation of the impact of HIVST on the testing uptake in rural and
urban workplaces.
2SLS

HIVST Technology
Standard errors
p-value
HIVST Technology
Standard errors
p-value
Age fix effect
Industry fix effect
Month fix effect
Intensity fix effect
Gender fix effect
Rural mean for HIV testing uptake
Urban mean for HIV testing uptake
Observations rural
Observations urban
F-stat 1st SLS rural
F-stat 1st SLS urban
R-squared 2nd SLS rural
R-squared 2nd SLS urban

Workplace
Rural
Testing uptake
0.315
(0.004)
0.002
Urban
Testing uptake
0.196
(0.003)
0.001
YES
YES
YES
YES
YES
0.946
0.900
3317
2942
95.112
88.058
0.077
0.067

Note: The results are from a 2SLS model. In the first stage equation, the dependent variable is the probability of
receiving the HIVST kit, while the instrument is a dummy variable equal to 1, for the infrequent testers, and 0, for
frequent testers. The dependent variable is the “confirmed HIV testing uptake” dummy variable in the second
stage regression. Both regressions include age, industry, region, month, distribution intensity, and gender fixed
effects. Source: Wits RHI workplace data provided by HSTAR group from 3 October 2017 to 31 January 2020.

The author now focuses on whether the positive testing outcomes are similar for
both genders. In order to explore such possible differences, the author repeated the same
regressions for males only and then for females only. In Table 4, one can see that HIVST
improves testing uptake more in the male population than in the female population.
More specifically, HIVST increases testing uptake by 34.6% in males compared to 20.1%
recorded in the female population group. These results reflect the South African working
environment, with men dominating the working space.
Lastly, the author analyses the potential existence of positive spillover effects of the
HIVST program on ART initiation, as having access to HIVST can encourage the uptake of
facility-based confirmatory testing and ART in infrequently testing clients with a positive
HIVST screening result. Table 5 shows that the HIVST distribution program increases
infrequently testing clients’ probability of opting for ART. More specifically, ART initiation
increased by 4.5 percentage points. This implies an effect of 7.6% of treated infrequently
testing clients. The impact is significant and suggests that HIVST increases testing uptake
and increases the probability of ART initiation—one of the main aims of introducing novel
HIV testing methods.
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Table 4. The 2SLS estimation of the impact of HIVST on testing uptake in males and females.
2SLS

HIVST Technology
Standard errors
p-value
HIVST Technology
Standard errors
p-value
Age fix effect
Industry fix effect
Region fix effect
Month fix effect
Intensity fix effect
Males mean for HIV testing uptake
Females mean for HIV testing uptake
Observations males
Observations females
F-stat 1st SLS males
F-stat 1st SLS females
R-squared 2nd SLS males
R-squared 2nd SLS females

Workplace
Males
HIV testing uptake
0.333
(0.003)
0.001
Females
HIV testing uptake
0.178
(0.005)
0.003
YES
YES
YES
YES
YES
0.962
0.884
3380
2879
97.445
81.549
0.078
0.071

Note: The results are from a 2SLS model. In the first stage equation, the dependent variable is the probability of
receiving the HIVST kit, while the instrument is a dummy variable equal to 1, for the infrequent testers, and 0, for
frequent testers. The dependent variable is the “confirmed HIV testing uptake” dummy variable in the second
stage regression. Both regressions include age, industry, region, month, distribution intensity, and gender fixed
effects. Source: Wits RHI workplace data provided by HSTAR group from 3 October 2017 to 31 January 2020.

Table 5. The 2SLS estimation of the impact of HIVST on ART uptake of infrequent testers.
2SLS
HIVST Technology
Standard errors
p-value
Age fix effect
Industry fix effect
Region fix effect
Month fix effect
Intensity fix effect
Gender fix effect
Mean for ART uptake
Observations
F-stat 1st SLS
R-squared 2nd SLS

Workplace
ART uptake
0.045
(0.021)
0.002
YES
YES
YES
YES
YES
YES
0.591
751
58.627
0.061

Note: The results are from a 2SLS model. In the first stage equation, the dependent variable is the probability of
receiving the HIVST kit, while the instrument is a dummy variable equal to 1, for the infrequent testers, and 0, for
frequent testers. The dependent variable is the “confirmed ART uptake” dummy variable in the second stage
regression. Both regressions include age, industry, region, month, distribution intensity, and gender fixed effects.
Source: Wits RHI workplace data provided by HSTAR group from 3 October 2017 to 31 January 2020.

3.3. Robustness Checks
In this section, the author provides robust checks to reinforce the validity of the current
findings. For comparison purposes, Tables 6 and 7 show the results of the OLS regressions
for the primary testing outcomes. The variable of interest is now the survey variable that
identifies recipients of HIVST. The author includes age, industry, region, month, intensity,
and gender fixed effects. As explained above, the author has reasons to believe that
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this is not a randomly assigned program. The OLS estimation may be overestimating or
underestimating the effects of the HIVST on testing uptake and ART initiation. Although the
author is already controlling for proxies of behavioural bias (age, gender, and distribution
intensity), there can still be other variables that determine HIVST program participation
that are unobserved and that may directly affect the testing outcomes and ART initiations
of the workers—such as access to the necessary information and proximity to healthcare
facilities, etc. Indeed, the results in Tables 6 and 7 are substantially larger in magnitude
than the baseline results of the 2SLS models presented in Tables 3 and 4. These two tables
(Tables 6 and 7) show the inflated biases of the OLS model. Hence, the author opted for the
2SLS model.
Table 6. OLS estimation of the impact of HIVST on testing uptake in rural and urban workplaces.
OLS

HIVST Technology
Standard errors
p-value
HIVST Technology
Standard errors
p-value
Age fix effect
Industry fix effect
Month fix effect
Intensity fix effect
Gender fix effect
Rural mean for HIV testing uptake
Urban mean for HIV testing uptake
Observations rural
Observations urban

Workplace
Rural
Testing uptake
0.537
(0.005)
0.003
Urban
Testing uptake
0.312
(0.004)
0.001
YES
YES
YES
YES
YES
0.946
0.900
3317
2942

Table 7. OLS estimation of the impact of HIVST on testing uptake in males and females.
OLS

HIVST Technology
Standard errors
p-value
HIVST Technology
Standard errors
p-value
Age fix effect
Industry fix effect
Region fix effect
Month fix effect
Intensity fix effect
Males mean for HIV testing uptake
Females mean for HIV testing uptake
Observations males
Observations females

Workplace
Males
HIV testing uptake
0.556
(0.004)
0.004
Females
HIV testing uptake
0.399
(0.005)
0.002
YES
YES
YES
YES
YES
0.962
0.884
3380
2879
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4. Discussion
Testing for HIV is widely seen as a crucial part of attaining the UNAIDS 95-95-95
targets aimed at reducing HIV incidence and deaths by 2030 [22]. The distribution of HIVST
kits targeting populations with low uptake of conventional testing in the workplace can
enhance testing uptake in previously undertested populations. This paper examined the
effects of HIVST on HIV testing uptake using a large longitudinal sample of the South
African working population.
The estimation shows that workplace HIVST distribution significantly affects the
testing outcomes of previously infrequently tested workers. This is an important finding
considering the large amount of existing evidence in the literature that shows the positive
long-term health outcomes of regular testing for HIV [23–25].
Regarding gender differences, the paper noted that HIVST effects are more substantial
in males than in females. These results are encouraging, considering that men generally
have a lower testing rate than females [26].
Moreover, when one analyses differences in the impact of HIVST for rural and urban
settings, one can see that HIVST increases testing uptake to a more considerable extent
in rural regions. Once again, these results are exciting considering that rural populations
are often characterised by low HIV testing due to limited resources [27]. Therefore, this
technology is key to the testing services for these vulnerable communities.
Finally, the author also analyses the existence of spillover effects of HIVST to ART
initiation. More specifically, the paper finds substantial increases in the probability of
ART initiation in those workers with a history of infrequent testing who tested positive,
similar to the evidence reported in Malawi [28,29]. Thus, the potential spillover effects of
HIVST on ART can be substantial, especially when the distribution focuses on men in the
rural workplace environment. The current results are significant from a policy point of
view, as they point out the essential positive effects of HIVST technology in the working
populations with low uptake of conventional testing. The lessons derived from this paper
can assist in the decision-making process of other developing countries seeking to adopt
this technology for their workplace distribution model.
Limitations
The author recognizes that additional aspects are not captured by the binary dummy
variables, which could potentially induce bias in the current estimation. For example, the
workplace data does not provide information on test kits spoiled during distribution. Thus,
the author interprets the current results as providing evidence of changes in the testing
uptake of the treated group, while not independently confirming the existing possibility of
spoiled kits due to client errors in using HIVST. However, the author believes this aspect
will not significantly influence the current results, since all clients received demonstrations
and training on using HIVST. Lastly, our telephonic follow-up discussion probed potential
stigmatizing information, such as the status of the testing worker and if the worker has
already initiated the ART. There is an existing possibility that the ART data does not reflect
the total of all cases enrolled on ART. A minority of workers were uncomfortable disclosing
this information.
5. Conclusions
The South African government has realized that HIVST distribution targeting the
vulnerable working class can enhance the testing uptake and ART initiation—thus breaking
the historical legacy of low testing appetite in this population segment. This paper has
examined the effect of HIVST technology on testing outcomes for both the frequent and infrequent populations using a large longitudinal sample of the South African working class.
The estimation shows that HIVST technology significantly improves testing uptake
and ART initiation in the infrequent testing worker population. This work may help other
countries to diversify the HIV testing policy by strengthening the case for HIV self-test
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technology as a much-needed investment for the UNAIDS 95–95–95 targets to end the
AIDS epidemic by 2030.
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